4D Molecular Therapeutics Inc. (FDMT)
10.96
-0.42 (3.69%)
Upcoming Events
Latest Headlines
Form 8-K 4D Molecular Therapeutic For: Jul 18
July 20, 2026 8:30 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
July 20, 2026 6:51 AM - StreetInsider
Form 4 4D Molecular Therapeutic For: Jul 09 Filed by: Kirn David
July 14, 2026 5:05 PM - SEC Filing
Form 144 4D Molecular Therapeutic Filed by: Kirn David
July 10, 2026 4:55 PM - SEC Filing
Form 144 4D Molecular Therapeutic Filed by: Kirn David
July 9, 2026 5:22 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 30 Filed by: Bizily Scott
July 2, 2026 4:08 PM - SEC Filing
Form 144 4D Molecular Therapeutic Filed by: Bizily Scott
June 30, 2026 4:39 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
June 30, 2026 6:44 AM - StreetInsider
Form 8-K 4D Molecular Therapeutic For: Jun 24
June 29, 2026 8:05 AM - SEC Filing
4DMT secures $200M credit facility with Hercules Capital
June 29, 2026 8:00 AM - StreetInsider
Vivani Medical adds August Moretti to board as Dean Baker retires
June 26, 2026 7:30 AM - StreetInsider
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
June 26, 2026 7:30 AM - Globe NewsWire
Form 4 4D Molecular Therapeutic For: Jun 23 Filed by: Bizily Scott
June 25, 2026 4:39 PM - SEC Filing
Form 144 4D Molecular Therapeutic Filed by: Bizily Scott
June 23, 2026 4:30 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 22 Filed by: Kirn David
June 23, 2026 4:19 PM - SEC Filing
Form 144 4D Molecular Therapeutic Filed by: Kirn David
June 22, 2026 5:58 PM - SEC Filing
Form 8-K 4D Molecular Therapeutic For: Jun 17
June 22, 2026 4:21 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: Tomasello Shawn
June 18, 2026 5:43 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: THEUER CHARLES
June 18, 2026 5:41 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: Miller-Rich Nancy
June 18, 2026 5:40 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: GRAY SUSANNAH
June 18, 2026 5:39 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: MILLIGAN JOHN F
June 18, 2026 5:33 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: SBLENDORIO GLENN
June 18, 2026 5:30 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 17 Filed by: Chacko Jacob
June 18, 2026 5:29 PM - SEC Filing
Form 4 4D Molecular Therapeutic For: Jun 01 Filed by: Kirn David
June 2, 2026 4:49 PM - SEC Filing
Form 144 4D Molecular Therapeutic Filed by: Kirn David
June 1, 2026 5:40 PM - SEC Filing
4DMT to Participate in Upcoming Investor Conferences
May 27, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: RA CAPITAL MANAGEMENT, L.P.
May 15, 2026 4:37 PM - SEC Filing
Form SCHEDULE 13G/A 4D Molecular Therapeutic Filed by: BIOTECHNOLOGY VALUE FUND L P
May 15, 2026 4:15 PM - SEC Filing
4DMT Announces New Employment Inducement Grants
May 15, 2026 4:05 PM - Globe NewsWire
Form EFFECT 4D Molecular Therapeutic
May 14, 2026 6:09 AM - SEC Filing
Form SCHEDULE 13G 4D Molecular Therapeutic Filed by: STATE STREET CORP
May 12, 2026 9:42 AM - SEC Filing
4D Molecular Therapeutics (FDMT) PT Lowered to $33 at Goldman Sachs
May 8, 2026 6:43 AM - StreetInsider
4D Molecular Therapeutics, Inc. (FDMT) Misses Q1 EPS by 1c
May 7, 2026 6:39 PM - StreetInsider
Form S-3 4D Molecular Therapeutic
May 7, 2026 4:58 PM - SEC Filing
Form 10-Q 4D Molecular Therapeutic For: Mar 31
May 7, 2026 4:16 PM - SEC Filing
Form 8-K 4D Molecular Therapeutic For: May 07
May 7, 2026 4:13 PM - SEC Filing
Form ARS 4D Molecular Therapeutic For: Dec 31
April 28, 2026 4:08 PM - SEC Filing
Form DEFA14A 4D Molecular Therapeutic
April 28, 2026 4:06 PM - SEC Filing
Form DEF 14A 4D Molecular Therapeutic For: Jun 17
April 28, 2026 4:06 PM - SEC Filing
Full Article List
